Chemotherapy Foundation Symposium

Welcome to the Highlights from Chemotherapy Foundation Symposium resource center. This is your central portal for research presented at the meeting. The resource center — which includes traditional articles and video commentaries — provides a comprehensive overview of advances related to all aspects of cancer. Many articles will be accompanied by perspectives in which experts put study results in context and offer insights into how findings will affect patient care.
Meeting News

Cognitive computing platform may help oncologists deliver subspecialist-level care

November 9, 2018
NEW YORK — A cognitive computing platform produced ranked treatment options that were largely concordant with expert opinions, according to…
Meeting News

Ribociclib-fulvestrant combination extends PFS for certain postmenopausal women with breast cancer

November 9, 2018
NEW YORK — The addition of ribociclib to fulvestrant significantly improved PFS among women with hormone receptor-positive, HER2-negative…
Meeting News

Nivolumab benefit in advanced head and neck cancer maintained regardless of age

November 9, 2018
NEW YORK — The OS benefit observed with nivolumab compared with investigator’s choice of single-agent chemotherapy for patients with…
Meeting News

More research needed to realize true benefit of PARP inhibitors in breast cancer

November 8, 2018
NEW YORK — The effectiveness of PARP inhibitors demonstrate a proof of principle that targeting DNA repair pathways can be a productive…
Meeting News

Immune-related adverse events manageable with vigilance, appropriate treatment

November 8, 2018
NEW YORK — Advances in immunotherapy have transformed cancer treatment but require clinicians to be vigilant for adverse events, according to a…
Meeting News

Triple combination appears safe, effective for advanced BRAF V600-mutant melanoma

November 8, 2018
NEW YORK — The addition of spartalizumab to dabrafenib and trametinib appeared safe and effective for previously untreated patients with…
Meeting News

Sarcoma treatments evolve as understanding of disease biology improves

November 7, 2018
NEW YORK — The treatment landscape in sarcoma is evolving rapidly as the research community recognizes the importance of matching therapies to…
Meeting News

Efficacy, safety must guide treatment sequencing decisions in chronic myeloid leukemia

November 7, 2018
NEW YORK — The approval of multiple tyrosine kinase inhibitors for chronic myeloid leukemia has greatly expanded the therapeutic armamentarium…
Meeting News

Second-line therapy for myelofibrosis remains ‘active area of research’

November 7, 2018
NEW YORK — Ruxolitinib has dramatically improved the care of patients with myelofibrosis, but new treatment strategies for patients who…
Meeting News

Telemedicine offers access to state-of-the-art cancer care in rural areas

November 22, 2017
NEW YORK — Every patient with cancer does not live in a major metropolitan area with direct access to specialized care, but there are ways to…